BGAC

CA:BIONEUTRA

BioNeutra

  • Stock

USD

Market Cap

2.79M

Beta: -

Volume Today

4.94K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Feb '14
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
890.20K
-
2.15M
142.07%
4.40M
104.18%
10.73M
143.92%
12.54M
16.88%
13.38M
6.70%
15.84M
18.36%
11.33M
28.49%
7.94M
29.95%
7.60M
4.22%
5.24M
31.10%
average payables
655.79K
-
1.93M
194.76%
2.41M
24.57%
6.21M
157.69%
8.38M
35.00%
9.46M
12.93%
16.29M
72.17%
17.51M
7.48%
14.44M
17.53%
14.78M
2.34%
14.18M
4.04%
average receivables
537.86K
-
1.64M
204.63%
1.88M
14.63%
2.65M
41.09%
3.37M
27.03%
3.76M
11.83%
3.92M
4.16%
2.47M
37.05%
1.68M
31.85%
1.41M
16.09%
1.16M
18.07%
book value per share
1.07
-
0.34
-
0.34
1.92%
0.30
11.57%
0.39
29.39%
0.10
73.97%
0.02
85.25%
-0.02
247.50%
-0.08
263.28%
-0.15
81.73%
capex per share
-0.03
-
-0.22
-
-0.06
74.56%
-0.04
21.87%
-0.02
59.11%
-0.01
71.47%
-0.00
67.80%
-0.01
262.03%
-0.00
26.34%
-0.00
89.56%
capex to depreciation
-0.59
-
-12.00
-
-2.20
81.70%
-1.78
18.85%
-0.84
52.68%
-0.10
87.89%
-0.04
59.33%
-0.21
403.43%
-0.18
12.22%
-0.02
90.06%
capex to operating cash flow
-0.05
-
-20.62
-
-2.54
87.70%
-0.90
64.66%
-0.28
68.41%
-0.34
18.47%
-0.05
84.10%
-1.02
1,814.15%
-0.24
76.19%
-0.03
88.38%
capex to revenue
-0.01
-
-0.62
-
-0.10
83.98%
-0.06
36.82%
-0.02
65.15%
-0.01
71.15%
-0.00
49.66%
-0.02
466.89%
-0.02
15.29%
-0.00
88.85%
cash per share
0.66
-
0.04
-
0.01
64.30%
0.03
134.19%
0.03
8.07%
0.01
65.45%
0.02
78.51%
0.02
10.12%
0.02
13.90%
0.04
188.28%
days of inventory on hand
162.44
-
254.42
-
330.63
29.95%
145.03
56.14%
225.49
55.48%
145.84
35.32%
142.03
2.61%
234.07
64.80%
237.33
1.40%
166.09
30.02%
days payables outstanding
119.63
-
91.75
-
220.85
140.72%
96.82
56.16%
164.58
69.99%
199.54
21.24%
266.98
33.80%
412.08
54.35%
510.04
23.77%
651.82
27.80%
days sales outstanding
51.71
-
35.33
-
52.62
48.96%
33.90
35.57%
43.97
29.69%
31.93
27.37%
24.79
22.37%
40.91
65.00%
29.89
26.93%
38.99
30.45%
debt to assets
0.02
-
0.34
1,532.84%
0.27
19.83%
0.32
19.11%
0.22
31.17%
0.22
0.32%
0.30
34.11%
0.33
9.42%
0.35
8.32%
0.48
35.39%
debt to equity
0.03
-
0.60
2,115.59%
0.63
5.42%
0.72
13.98%
0.49
31.32%
1.59
222.29%
10.09
532.81%
-6.67
166.06%
-1.87
72.02%
-1.22
34.57%
dividend yield
0.02
-
earnings yield
3.26
-
0.03
-
0.17
510.26%
-0.19
215.01%
0.48
345.97%
-1.97
513.75%
-0.60
69.49%
-0.43
27.80%
-13.27
2,954.66%
-1.89
85.77%
enterprise value
-982.58K
-
-1.80M
82.86%
13.98M
878.21%
15.79M
12.95%
14.66M
7.16%
13.95M
4.86%
13.37M
4.18%
12.30M
7.97%
12.57M
2.16%
6.50M
48.25%
6.79M
4.36%
enterprise value over ebitda
-0.57
-
9.62
-
4.08
57.61%
12.99
218.53%
4.12
68.27%
-1.78
143.20%
-10.41
484.78%
-12.22
17.37%
-4.80
60.75%
-162.87
3,295.67%
ev to operating cash flow
-0.98
-
29.04
-
15.55
46.46%
6.53
58.01%
4.80
26.50%
18.89
293.67%
8.58
54.57%
46.36
440.13%
7.76
83.27%
9.93
28.03%
ev to sales
-0.13
-
0.87
-
0.61
30.27%
0.46
24.93%
0.37
18.92%
0.35
4.14%
0.51
43.87%
0.82
59.97%
0.49
40.48%
0.60
22.77%
free cash flow per share
0.53
-
-0.21
-
-0.03
83.80%
0.01
114.90%
0.05
795.84%
0.01
77.68%
0.03
188.56%
-0.00
100.42%
0.01
11,224.56%
0.02
15.33%
free cash flow yield
4.61
-
-1.45
-
-0.24
83.24%
0.04
115.94%
0.32
724.37%
0.07
76.72%
0.22
195.58%
-0.00
100.40%
2.88
329,233.76%
0.60
79.36%
graham net net
-0.76
-
-0.13
-
-0.21
69.85%
-0.18
14.00%
-0.19
1.70%
-0.41
117.44%
-0.36
10.50%
-0.34
5.43%
-0.40
15.21%
-0.42
4.85%
graham number
3.02
-
0.17
-
0.43
145.17%
0.42
2.49%
0.77
85.97%
0.79
1.63%
0.16
79.04%
0.17
6.11%
0.34
93.67%
0.41
20.20%
income quality
1.48
-
2.68
-
0.94
64.92%
-1.93
305.59%
0.94
148.42%
-0.06
106.07%
-0.39
579.89%
-0.10
75.22%
-0.29
199.59%
-0.32
12.99%
intangibles to total assets
0.11
-
0.28
151.55%
0.16
43.88%
0.09
39.77%
0.08
15.53%
0.05
40.97%
0.03
29.73%
0.03
18.85%
0.02
29.25%
0.02
13.02%
0.02
5.50%
interest coverage
42.28
-
3.55
-
5.67
59.49%
-0.00
100.05%
4.27
159,107.22%
-16.49
486.20%
-6.98
57.68%
-6.02
13.71%
-5.48
9.02%
interest debt per share
0.02
-
0.21
-
0.23
10.43%
0.23
1.17%
0.21
10.17%
0.18
14.87%
0.16
8.18%
0.16
2.98%
0.16
2.36%
0.18
11.73%
inventory turnover
2.25
-
1.43
-
1.10
23.05%
2.52
127.97%
1.62
35.68%
2.50
54.61%
2.57
2.68%
1.56
39.32%
1.54
1.38%
2.20
42.90%
invested capital
0.03
-
0.60
2,115.59%
0.63
5.42%
0.72
13.98%
0.49
31.32%
1.59
222.29%
10.09
532.81%
-6.67
166.06%
-1.87
72.02%
-1.22
34.57%
market cap
208.02K
-
6.50M
-
6.41M
1.45%
5.99M
6.50%
6.51M
8.67%
6.31M
3.08%
6.16M
2.37%
6.51M
5.72%
220.09K
96.62%
1.12M
407.12%
net current asset value
-159.52K
-
3.76M
2,455.89%
-2.08M
155.32%
-1.17M
43.63%
-2.74M
133.97%
1.25M
145.61%
-8.64M
790.51%
-10.53M
21.91%
-11.19M
6.26%
-13.82M
23.58%
-14.99M
8.42%
net debt to ebitda
-0.69
-
5.15
-
2.42
52.92%
7.68
216.97%
2.20
71.39%
-0.94
142.76%
-5.20
452.95%
-5.89
13.26%
-4.63
21.30%
-136.09
2,836.62%
net income per share
0.38
-
0.00
-
0.02
489.77%
-0.03
207.53%
0.07
367.29%
-0.27
496.70%
-0.08
70.21%
-0.06
23.67%
-0.06
3.25%
-0.05
20.50%
operating cash flow per share
0.56
-
0.01
-
0.02
106.88%
0.05
121.08%
0.06
29.44%
0.02
75.92%
0.03
102.55%
0.01
81.09%
0.02
209.32%
0.02
10.17%
payables turnover
3.05
-
3.98
-
1.65
58.46%
3.77
128.10%
2.22
41.17%
1.83
17.52%
1.37
25.26%
0.89
35.21%
0.72
19.21%
0.56
21.75%
receivables turnover
7.06
-
10.33
-
6.94
32.87%
10.77
55.21%
8.30
22.89%
11.43
37.68%
14.72
28.81%
8.92
39.39%
12.21
36.85%
9.36
23.34%
research and ddevelopement to revenue
0.02
-
0.02
-
0.01
40.43%
0.01
52.42%
0.01
78.56%
0.01
7.59%
0.01
8.65%
0.00
92.95%
-0.00
263.03%
0.01
1,148.14%
return on tangible assets
0.12
-
0.01
-
0.03
309.71%
-0.04
225.05%
0.08
299.92%
-0.38
564.44%
-0.16
57.47%
-0.14
14.97%
-0.15
10.32%
-0.14
9.59%
revenue per share
4.21
-
0.36
-
0.57
58.85%
0.70
23.67%
0.82
17.34%
0.81
1.12%
0.52
36.03%
0.33
36.14%
0.29
13.05%
0.27
6.33%
roe
0.35
-
0.01
-
0.07
478.68%
-0.08
221.61%
0.17
306.58%
-2.62
1,623.77%
-5.29
101.99%
2.74
151.75%
0.78
71.58%
0.34
56.26%
roic
0.51
-
0.01
-
0.05
939.13%
-0.00
100.12%
0.08
124,500.85%
-0.76
1,083.58%
-0.38
49.86%
-0.46
19.59%
-0.83
81.90%
-0.81
3.05%
sales general and administrative to revenue
0.21
-
0.27
-
0.16
41.53%
0.16
2.45%
0.14
11.50%
0.22
55.02%
0.23
1.35%
0.29
29.35%
0.28
3.07%
0.14
49.84%
shareholders equity per share
1.07
-
0.34
-
0.34
1.92%
0.30
11.57%
0.39
29.39%
0.10
73.97%
0.02
85.25%
-0.02
247.50%
-0.08
263.28%
-0.15
81.73%
stock based compensation to revenue
0.05
-
0.01
-
0.01
82.63%
0.00
98.96%
0.03
-
tangible asset value
1.24M
-
6.77M
446.53%
10.98M
62.21%
12.32M
12.21%
11.48M
6.81%
16.17M
40.85%
3.63M
77.59%
64.35K
98.22%
-1.43M
2,329.71%
-4.18M
191.38%
-6.51M
55.81%
tangible book value per share
0.69
-
0.24
-
0.27
10.03%
0.25
6.81%
0.35
40.85%
0.08
77.83%
0.00
98.22%
-0.03
2,329.71%
-0.09
191.38%
-0.15
71.69%
working capital
350.48K
-
3.98M
1,034.72%
6.76M
69.97%
7.78M
15.11%
5.43M
30.16%
9.33M
71.67%
-1.89M
120.25%
-4.16M
120.27%
-4.85M
16.50%
-7.20M
48.44%
-7.81M
8.55%

All numbers in USD (except ratios and percentages)